Litcius/Paper detail

Cognitive improving actions of tofacitinib in a mouse model of Alzheimer disease involving TNF-α, IL-6, PI3K-Akt and GSK-3β signalling pathway

Songtao Sui, Hailing Lv

2022International Journal of Neuroscience12 citationsDOI

Abstract

: It is concluded that tofactinib improves the condition of dementia of Alzheimer's type, possibly through down regulation of T NF-α and IL-6 and instigation of P I3K-Akt-p-GSK-3β signalling system in the hippocampus of Aβ-treated mice.

Topics & Concepts

Morris water navigation taskProtein kinase BHippocampusPI3K/AKT/mTOR pathwayLY294002MedicineInternal medicineEndocrinologyPharmacologyPsychologyNeuroscienceChemistrySignal transductionBiochemistryAlzheimer's disease research and treatmentsTryptophan and brain disordersNeuroinflammation and Neurodegeneration Mechanisms
Cognitive improving actions of tofacitinib in a mouse model of Alzheimer disease involving TNF-α, IL-6, PI3K-Akt and GSK-3β signalling pathway | Litcius